Lakewood-Amedex Advances Nu-3 Gel Toward Phase 2a Trial
SARASOTA, Fla., July 15, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced encouraging preclinical safety results supporting dose selection for the...
VRE
Advertisement
Lakewood-Amedex Backs PASTEUR Act to Fight AMR Crisis
SARASOTA, Fla., July 7, 2026 Lakewood-Amedex Biotherapeutics has announced its support for the reintroduction of the bipartisan Pioneering Antimicrobial...
Acurx Pharmaceuticals Showcases DNA pol IIIC Antibiotic Breakthrough
STATEN ISLAND, N.Y., June 16, 2026 Acurx Pharmaceuticals has announced the presentation of new scientific findings from its ongoing...
Advertisement
